Target intelligence / Profile preview

UNC79 subunit of NALCN channel complex (UNC79)

Target
UNC79
Molecular classification
Ion channel auxiliary subunit, Accessory/scaffold protein, Cytoplasmic channelosome component
01

Overview

UNC79 is a large cytoplasmic scaffold protein required as an accessory subunit of the NALCN (sodium leak channel, nonselective) channel complex—sometimes called the NALCN channelosome—in excitable tissues such as neurons[2][3][5][7]. It forms a super-helical heterodimer with UNC80, which assembles with NALCN and FAM155A on the cytoplasmic side of the channel. UNC79 is crucial for the assembly, membrane localization, and functional modulation of NALCN, influencing persistent sodium leak currents that establish neuronal resting membrane potential, regulate neuronal excitability, and impact motor and circadian functions. Genetic loss or mutation of UNC79, NALCN, or UNC80 in mice is lethal, and in humans, variants in these genes cause neurodevelopmental channelopathies featuring hypotonia, intellectual disability, and motor impairments[2][3][5][7]. UNC79 supports the channel complex’s structure but is not itself a traditional druggable target; research on its role in disease and potential modulation is ongoing.

Other names
UNC79KIAA1409unc-79 homolog (C. elegans)
02

Mechanism of action

Not applicable for UNC79 specifically; for the complex: modulation of NALCN channel function via protein assembly and localization

03

Biological functions

Promotes assembly and stability of the NALCN channel complexTargets/channel localization to the neuronal membraneRegulates persistent sodium leak currents, thus contributing to neuronal resting membrane potential and excitabilityScaffold for protein-protein interactions, potentially integrating regulatory signals
04

Disease associations

Neurodevelopmental disease (mutations in UNC79, NALCN, or auxiliary subunits lead to channelopathies; recent studies link heterozygous UNC79 variants to neurodevelopmental syndromes in humans)Intellectual disability, infantile hypotonia with psychomotor retardation, and abnormal motor function (when disrupted)Other neurological defects
05

Safety considerations

No specific safety concerns described for targeting UNC79—however, genetic disruption causes severe neurological disease and is lethal in animal modelsTargeting UNC79 therapeutically would likely risk serious adverse CNS effects.
06

Biomarkers

None validated for UNC79 alone (mutations in UNC79, UNC80, or NALCN genes may be assessed as genetic biomarkers in rare neurological syndromes)

Beyond the preview

Go deeper on UNC79 subunit of NALCN channel complex (UNC79).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UNC79 subunit of NALCN channel complex (UNC79).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call